Remove tag january-ventures
article thumbnail

Six recent Voice/Conversational AI innovations for older adults

Aging in Place Technology Watch

January 24, 2022) " Voice-activated technology can reduce loneliness among senior living residents and help with the design of “gerontechnology” aimed at older adults, according to the results of a University of Nebraska-Lincoln demonstration project. Market Overview Technology for Aging January 2022. Learn more. Learn more.

article thumbnail

Four Aging and Health Technology Blog Posts from July 2020

Aging in Place Technology Watch

A new venture capital firm formed that is focused on the older adult market. The 127,000 CES 2020 attendees in January saw exhibit areas and innovations focused on older adults and what they need. category tags: hearables/hearing technology , medication management , social isolation , covid-19 , Aging, ageism.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Five Health and Aging Blog Posts from August 2020

Aging in Place Technology Watch

The world’s largest annual trade event that many tech firms would spend the fall preparing for, CES in January 2021, has moved to all-online. We get pretty excited when a new venture firm starts up in the US that focuses on older adults. The irreversible telehealth boom may be slowing and yet, older adults may be unable to benefit.

article thumbnail

The most-read tech and aging blog posts from 2019

Aging in Place Technology Watch

Strolling is not the right word, but as we approached the Las Vegas Convention Center last January, Google Assistant was on giant billboards all around – with competing and nearby giant Amazon Alexa signs. Past venture capital investment in home care boggles the mind. Voice First -- The year began and ended with speaking.

article thumbnail

The Foursquare Framework for investing in HealthTech based on Medicine Needs and Social Needs

Lloyd Price

Krishna Yeshwant, a doctor and investor with GV, Alphabet's venture firm, takes a lot of meetings with entrepreneurs that have lofty goals to fix health care. In January, a single therapy to treat a rare form of blindness received a price tag of $850,000. But different patients have different needs. Who's left out?